Health Care/Hospital News Releases-PR Newswire APAC

Health Care/Hospital

APAC
Global

CStone announces first patient dosed in China for Phase I/II registrational bridging trial of avapritinib in advanced GIST

SUZHOU, China, Aug. 26, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient inChina has been dosed in the Phase I/II bridging study of avapritinib, which was discovered by CStone's partner Blueprint Medicines. This stand-alone registrational b...

2019-08-26 11:21

Atonarp Inc. Announces $33 Million Series C Funding Round Completion

- Financing round brings five new investors to Atonarp, including Japan Post Investment Corporation and SBI Investment Co., Ltd. - Series C was oversubscribed as investor demand was driven by the company's accelerating development progress of disruptive healthcare diagnostics platform. - Fundin...

2019-08-26 07:00 218

Atonarp Inc. Announces $33 Million Series C Funding Round Completion

Concord Medical Reports Financial Results for the First Half of 2019

BEIJING, Aug. 23, 2019 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a specialty hospital management group and an operator of the network of radiotherapy and diagnostic imaging centers inChina, today announced its unaudited consolidate...

2019-08-24 06:00 2294

111 Signs Strategic Partnership with TK.CN to Empower Insurance Service

SHANGHAI, Aug. 23, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced that it has signed a strategic partnership agreement with TK.CN, a wholly-owned subsidiary of Taikang Insurance Group, a Fortune 50...

2019-08-23 21:20 2556

Shares of Ping An Good Doctor Jumped Nearly 50% after the Results, with Banks Maintaining a "Buy" Rating

SHANGHAI, Aug. 23, 2019 /PRNewswire/ -- The world largest online healthcare platform,Ping An Good Doctor (01833.HK), has seen its share price rise sharply recently, closing at HK$48.35 on 23 August, up 6.73%. The company's share price has soared by 48.7% since they announced the 1H2019 earning re...

2019-08-23 20:07 2763

CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO, 2019 CSCO Annual Meeting) has accepted three abstracts on the clinical trials of CS1001 (Anti...

2019-08-23 11:26 930

CStone completes registration filing for the Phase I trial of CDK4/6 inhibitor CS3002 in Australia and will soon initiate the study

SUZHOU, China, Aug. 23, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the Company has recently received ethics approval from the Human Research Ethics Committee inAustralia for the Phase I clinical trial of CS3002, andAustralia's Therape...

2019-08-23 11:20 925

New IDTechEx Report Shows Wearables Are Now Worth Over $50bn Per Year as Growth Quietly Continues

BOSTON, Aug. 23, 2019 /PRNewswire/ -- IDTechEx's latest report on the topic has found that wearable technology products will be worth over$50bn in 2019. In fact, the total market size has doubled in size since 2014, placing wearables as one of the most consistently successful markets around consu...

2019-08-23 10:00 973

New IDTechEx Report Shows Wearables Are Now Worth Over $50bn Per Year as Growth Quietly Continues

Gencurix's Study Explores the Difference between GenesWell BCT and Oncotype DX

SEOUL, South Korea, Aug. 23, 2019 /PRNewswire/ -- Gencurix, Inc., a molecular diagnostics company, announced the publication of a new study onFrontiers in Oncology comparing GenesWell(TM) BCT, a prognostic multigene test, with Genomic Health's Oncotype DX in patients with early-stage breast cance...

2019-08-23 08:00 904

MCRA Hires Reimbursement Leader Tonya N. Dowd, MPH, as Vice President of Reimbursement, Health Economics, and Market Access

WASHINGTON, Aug. 23, 2019 /PRNewswire/ -- MCRA, LLC (www.mcra.com), a leading medical device advisory firm and Clinical Research Organization (CRO) integrating US and international regulatory, clinical research, reimbursement, healthcare compliance, and quality assurance, is pleased to announce a...

2019-08-23 08:00 932

/C O R R E C T I O N -- EW Healthcare Partners/

In the news release, EW Healthcare Partners Raises Over $745 Million Fund 2a, issued23-Aug-2019 by EW Healthcare Partners over PR Newswire, we are advised by the company that the headline and first paragraph should read "Fund 2" rather than "Fund 2a" as originally issued inadvertently. The comple...

2019-08-23 07:07 1057

Voronoi selects CDD Vault platform to manage its Drug Discovery Data

INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ -- Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collabora...

2019-08-23 06:36 956

Regulation Needs to Keep Pace With Global Cannabis Legalisation in 2019 - Prohibition Partners

LONDON, Aug. 22, 2019 /PRNewswire/ -- The number of countries to legalise medical cannabis has risen nine-fold in the last five years, as global attitudes towards cannabis have shifted in favour of liberalisation. In 2019, 43 countries have legalised medical cannabis, with a host more allowing p...

2019-08-22 19:54 825

Luye Pharma's Investigational Drug Ansofaxine Hydrochloride Extended Release Tablets to Start Clinical Trials in Japan

TOKYO, Aug. 22, 2019 /PRNewswire/ -- Luye Pharma Group has announced its submission of the clinical trials application for a new chemical drug, Ansofaxine Hydrochloride Extended Release Tablets (LY03005) for the treatment of depression inJapan, with the trials expected to begin soon. Meanwhile, p...

2019-08-22 15:36 835

The CareVoice Closes Eight Figure USD Series A Funding Round

SHANGHAI, Aug. 22, 2019 /PRNewswire/ -- The CareVoice, an international health insurtech company based inChina, announced today that it has successfully raised an eight-figure USD Series A funding round. The round was led by a global investment group, LUN Partners Group, and a global investment m...

2019-08-22 12:48 947

The CareVoice Closes Eight Figure USD Series A Funding Round

Tahir Foundation launches new partnership to end malaria in Indonesia

JAKARTA, Indonesia, Aug. 22, 2019 /PRNewswire/ -- In a joint partnership, the Tahir Foundation and the Asia Pacific Leaders Malaria Alliance (APLMA)[1] announced the launch of M2030 inIndonesia. Started by APLMA in 2018, M2030[2] is a movement that brings together businesses, consumers and ...

2019-08-22 08:00 902

Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China

SUZHOU, China, Aug. 22, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that it has entered into a licensing agreement with Eli Lilly and Company (Lilly) for th...

2019-08-22 07:30 935

Super Antioxidant Ergothioneine Achieves GRAS Status from FDA

Decision Drives Anti-Aging Market Emerging Studies Reveal Ergothioneine consumption is Correlated to Reducing Mild Cognitive Impairment RANCHO SANTA MARGARITA, California, Aug. 22, 2019 /PRNewswire/ -- Southern California-based ingredient supplier and manufacturer, Blue California announced th...

2019-08-22 04:50 952

Pneuma Respiratory, Inc. Announces New Chairman of the Board

BOONE, North Carolina, Aug. 22, 2019 /PRNewswire/ -- Pneuma Respiratory, Inc. announced that Board memberJay Morgan has assumed the position of Chairman of the Board. Pneuma's previous Chairman,Walt Robb, will remain a member of the Board of Directors. Jay Morgan served as VP Global Innovation a...

2019-08-22 03:17 931

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

The technology should reduce costs to patients and accelerate drug development BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...

2019-08-22 01:39 884

12 3 4 5 ... 732